| Dr Darren Jilek, PHD | |
|
39218 Prairie Rd, Mellette, SD 57461-5206 | |
| (605) 228-4877 | |
| Not Available |
| Full Name | Dr Darren Jilek |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 10 Years |
| Location | 39218 Prairie Rd, Mellette, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215300066 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 536 (South Dakota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northern Plains Psychological Associates Llc | 4981088713 | 5 |
News Archive
By creating a unique system of blood vessels that is engineered to interact with the tissue surrounding an implanted device, the longevity and function of these devices may be better preserved, according to a study led by researchers in the University of Louisville/ Jewish Hospital's Cardiovascular Innovation Institute (CII).
Hundreds of new medical marijuana dispensaries have cropped up in Denver, Boulder and other Colorado cities, causing the state to stop accepting walk-up applications from people seeking cards that allow them to buy the plant, CNBC/USA Today reports. Would-be medical-marijuana consumers will now have to mail in their applications. "The changes are necessary due to the explosive growth in the number of medical marijuana applications," said a state health official.
PTC Therapeutics, Inc. (PTC) today announced that it has reached a major research milestone in its collaboration with Schering-Plough Corporation (NYSE: SGP) receiving a $2 million payment in connection with the designation of a development candidate for the treatment of hepatitis C virus (HCV) infection.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, has been issued via an exclusive license from Emory University, a US Patent for its "DNA expression vectors and methods of use. Issued on September 14, 2010, the patent claims cover novel vectors and novel HIV vaccine inserts.
A recent study addresses the effects of controlling non-pharmaceutical interventions to develop a deeper understanding of their influence on the resurgence of COVID-19.
› Verified 6 days ago
| Entity Name | Lutheran Social Services Of South Dakota Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194885723 PECOS PAC ID: 9638163140 Enrollment ID: O20040408000931 |
News Archive
By creating a unique system of blood vessels that is engineered to interact with the tissue surrounding an implanted device, the longevity and function of these devices may be better preserved, according to a study led by researchers in the University of Louisville/ Jewish Hospital's Cardiovascular Innovation Institute (CII).
Hundreds of new medical marijuana dispensaries have cropped up in Denver, Boulder and other Colorado cities, causing the state to stop accepting walk-up applications from people seeking cards that allow them to buy the plant, CNBC/USA Today reports. Would-be medical-marijuana consumers will now have to mail in their applications. "The changes are necessary due to the explosive growth in the number of medical marijuana applications," said a state health official.
PTC Therapeutics, Inc. (PTC) today announced that it has reached a major research milestone in its collaboration with Schering-Plough Corporation (NYSE: SGP) receiving a $2 million payment in connection with the designation of a development candidate for the treatment of hepatitis C virus (HCV) infection.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, has been issued via an exclusive license from Emory University, a US Patent for its "DNA expression vectors and methods of use. Issued on September 14, 2010, the patent claims cover novel vectors and novel HIV vaccine inserts.
A recent study addresses the effects of controlling non-pharmaceutical interventions to develop a deeper understanding of their influence on the resurgence of COVID-19.
› Verified 6 days ago
| Entity Name | Dakota Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346699675 PECOS PAC ID: 4789952706 Enrollment ID: O20170615002625 |
News Archive
By creating a unique system of blood vessels that is engineered to interact with the tissue surrounding an implanted device, the longevity and function of these devices may be better preserved, according to a study led by researchers in the University of Louisville/ Jewish Hospital's Cardiovascular Innovation Institute (CII).
Hundreds of new medical marijuana dispensaries have cropped up in Denver, Boulder and other Colorado cities, causing the state to stop accepting walk-up applications from people seeking cards that allow them to buy the plant, CNBC/USA Today reports. Would-be medical-marijuana consumers will now have to mail in their applications. "The changes are necessary due to the explosive growth in the number of medical marijuana applications," said a state health official.
PTC Therapeutics, Inc. (PTC) today announced that it has reached a major research milestone in its collaboration with Schering-Plough Corporation (NYSE: SGP) receiving a $2 million payment in connection with the designation of a development candidate for the treatment of hepatitis C virus (HCV) infection.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, has been issued via an exclusive license from Emory University, a US Patent for its "DNA expression vectors and methods of use. Issued on September 14, 2010, the patent claims cover novel vectors and novel HIV vaccine inserts.
A recent study addresses the effects of controlling non-pharmaceutical interventions to develop a deeper understanding of their influence on the resurgence of COVID-19.
› Verified 6 days ago
| Entity Name | Northern Plains Psychological Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104100544 PECOS PAC ID: 4981088713 Enrollment ID: O20220829001643 |
News Archive
By creating a unique system of blood vessels that is engineered to interact with the tissue surrounding an implanted device, the longevity and function of these devices may be better preserved, according to a study led by researchers in the University of Louisville/ Jewish Hospital's Cardiovascular Innovation Institute (CII).
Hundreds of new medical marijuana dispensaries have cropped up in Denver, Boulder and other Colorado cities, causing the state to stop accepting walk-up applications from people seeking cards that allow them to buy the plant, CNBC/USA Today reports. Would-be medical-marijuana consumers will now have to mail in their applications. "The changes are necessary due to the explosive growth in the number of medical marijuana applications," said a state health official.
PTC Therapeutics, Inc. (PTC) today announced that it has reached a major research milestone in its collaboration with Schering-Plough Corporation (NYSE: SGP) receiving a $2 million payment in connection with the designation of a development candidate for the treatment of hepatitis C virus (HCV) infection.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, has been issued via an exclusive license from Emory University, a US Patent for its "DNA expression vectors and methods of use. Issued on September 14, 2010, the patent claims cover novel vectors and novel HIV vaccine inserts.
A recent study addresses the effects of controlling non-pharmaceutical interventions to develop a deeper understanding of their influence on the resurgence of COVID-19.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Darren Jilek, PHD 39218 Prairie Rd, Mellette, SD 57461-5206 Ph: () - | Dr Darren Jilek, PHD 39218 Prairie Rd, Mellette, SD 57461-5206 Ph: (605) 228-4877 |
News Archive
By creating a unique system of blood vessels that is engineered to interact with the tissue surrounding an implanted device, the longevity and function of these devices may be better preserved, according to a study led by researchers in the University of Louisville/ Jewish Hospital's Cardiovascular Innovation Institute (CII).
Hundreds of new medical marijuana dispensaries have cropped up in Denver, Boulder and other Colorado cities, causing the state to stop accepting walk-up applications from people seeking cards that allow them to buy the plant, CNBC/USA Today reports. Would-be medical-marijuana consumers will now have to mail in their applications. "The changes are necessary due to the explosive growth in the number of medical marijuana applications," said a state health official.
PTC Therapeutics, Inc. (PTC) today announced that it has reached a major research milestone in its collaboration with Schering-Plough Corporation (NYSE: SGP) receiving a $2 million payment in connection with the designation of a development candidate for the treatment of hepatitis C virus (HCV) infection.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, has been issued via an exclusive license from Emory University, a US Patent for its "DNA expression vectors and methods of use. Issued on September 14, 2010, the patent claims cover novel vectors and novel HIV vaccine inserts.
A recent study addresses the effects of controlling non-pharmaceutical interventions to develop a deeper understanding of their influence on the resurgence of COVID-19.
› Verified 6 days ago